Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Cohen

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Journal of Thrombosis and Thrombolysis|April 20, 2011
Dose selection for a direct and selective factor IXa inhibitor and its complementary reversal agent: translating pharmacokinetic and pharmacodynamic properties of the REG1 system to clinical trial designT J Povsic, M G Cohen, M Y Chan, et al.
The American Journal of Cardiology|March 23, 2000
Outcomes following interventions in small coronary arteries with the use of hand-crimped Palmaz-Schatz stentsM G Cohen, D F Kong, J J Warner, et al.
Journal of the American College of Cardiology|November 30, 1999
Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesM G Cohen, C B Granger, E M Ohman, et al.
American Heart Journal|March 7, 2001
Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America: results from the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trialM G Cohen, C M Pacchiana, R Corbalán, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Journal of Thrombosis and Thrombolysis|April 20, 2011
Dose selection for a direct and selective factor IXa inhibitor and its complementary reversal agent: translating pharmacokinetic and pharmacodynamic properties of the REG1 system to clinical trial designT J Povsic, M G Cohen, M Y Chan, et al.
The American Journal of Cardiology|March 23, 2000
Outcomes following interventions in small coronary arteries with the use of hand-crimped Palmaz-Schatz stentsM G Cohen, D F Kong, J J Warner, et al.
Journal of the American College of Cardiology|November 30, 1999
Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesM G Cohen, C B Granger, E M Ohman, et al.
American Heart Journal|March 7, 2001
Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America: results from the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trialM G Cohen, C M Pacchiana, R Corbalán, et al.
Pageof 6